Procter & Gamble Shares Face Headwinds from Sluggish U.S. Consumer Demand

Often viewed as a defensive stock during market turbulence, Procter & Gamble’s latest quarterly results revealed unexpected challenges. The consumer goods behemoth reported earnings that met forecasts, but its revenue fell short of Wall Street’s projections. This miss is primarily attributed to a noticeable pullback in consumer spending within its crucial home market of the United States, a trend now under intense investor scrutiny.

Earnings and Shareholder Returns Hold Firm Amid Revenue Pressure

For its second fiscal quarter, ending December 31, 2025, P&G posted revenue of $22.2 billion. This figure represents a modest 1% year-over-year increase but failed to reach analyst expectations. A more telling metric is organic sales, which strip out the impacts of currency fluctuations and acquisitions. These sales showed no growth compared to the prior-year period.

Despite the mixed operational performance, the company’s commitment to shareholder returns remained unwavering. During the quarter, $4.8 billion was returned to investors through dividends and share repurchases. On the bottom line, core earnings per share (Core EPS)—a key adjusted metric—came in at $1.88, matching the prior year’s result and slightly exceeding the consensus estimate of $1.86. However, reported diluted earnings per share declined by 5% to $1.78, weighed down by costs associated with restructuring initiatives.

Geographic and Segment Performance Reveals a Split Picture

The weakness was heavily concentrated in North America, where cautious consumer behavior directly impacted sales volumes. This contrasted with stronger performances in other regions, with Latin America and Europe posting organic sales growth of 8% and 6%, respectively. The pressure in the U.S. market also affected profitability: the gross margin contracted by 120 basis points to 51.2%, and operating income fell by 7%.

Should investors sell immediately? Or is it worth buying Procter & Gamble?

A breakdown by product category shows a divided performance. The Beauty and Health Care segments each delivered 5% sales growth, fueled by volume increases in hair care products. Conversely, the Baby, Feminine & Family Care segment struggled, with volume dropping 5% and sales declining 3%. Beyond broader consumer softness, this decline had a technical component; in the year-ago quarter, retailers had significantly built up inventories ahead of potential port strikes, making the current comparison more difficult.

Management Maintains Outlook, Pinning Hopes on Second Half

Confronted with these challenges, P&G’s leadership reaffirmed its full-year fiscal 2026 guidance for organic sales growth and adjusted profit. The only revision was a slight downward adjustment to the GAAP earnings growth forecast, now expected to be in the range of 1% to 6%, due to the aforementioned restructuring expenses.

CEO Shailesh Jejurikar expressed confidence that strategic innovations and investments would yield improved results in the latter half of the fiscal year. The success of this strategy will become clearer on April 17, 2026, when the company reports its third-quarter figures. Despite the recent news flow, P&G’s stock price has demonstrated resilience, trading at $150.38 and maintaining a year-to-date gain of approximately 6%.